{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:29:34Z","timestamp":1782844174047,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.tmaid.2020.101700","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T21:16:39Z","timestamp":1587762999000},"page":"101700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Relapsing cutaneous leishmaniasis in a patient requiring TNF-\u03b1-inhibitor Infliximab for Takayasu-arteritis: Case report and review of the literature"],"prefix":"10.1016","volume":"37","author":[{"given":"Melina","family":"Heinemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till F.","family":"Omansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Hennigs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"V\u00f6lker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Menz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marylyn M.","family":"Addo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schmiedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2020.101700_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13071-017-2028-5","article-title":"The history of leishmaniasis","volume":"10","author":"Steverding","year":"2017","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.tmaid.2020.101700_bib2","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3201\/eid1210.060169","article-title":"Leishmaniasis in ancient Egypt and Upper nubia","volume":"12","author":"Zink","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101700_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.tmaid.2020.101700_bib4","series-title":"Leishmaniasis","volume":"Fact sheet No. 375","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.tmaid.2020.101700_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101700_bib6","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2020.101700_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s40506-015-0038-4","article-title":"Cutaneous leishmaniasis: current treatment practices in the USA for returning travelers","volume":"7","author":"Eiras","year":"2015","journal-title":"Curr Treat Options Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101700_bib8","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1462-5822.2005.00626.x","article-title":"Immunologic memory in cutaneous leishmaniasis","volume":"7","author":"Scott","year":"2005","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.tmaid.2020.101700_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1590\/S0100-879X1998000100020","article-title":"Cytokine profile and pathology in human leishmaniasis","volume":"31","author":"Ribeiro-de-Jesus","year":"1998","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.tmaid.2020.101700_bib10","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI116341","article-title":"Cytokine patterns in the pathogenesis of human leishmaniasis","volume":"91","author":"Pirmez","year":"1993","journal-title":"J Clin Invest"},{"issue":"Suppl 8","key":"10.1016\/j.tmaid.2020.101700_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1610-0379.2011.07820.x","article-title":"Diagnosis and therapy of cutaneous and mucocutaneous Leishmaniasis in Germany","volume":"9","author":"Boecken","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.tmaid.2020.101700_bib12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1128\/JCM.40.2.601-606.2002","article-title":"PCR-based diagnosis of acute and chronic cutaneous leishmaniasis caused by Leishmania (Viannia)","volume":"40","author":"Weigle","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tmaid.2020.101700_bib13","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1086\/382135","article-title":"Persistence of leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure?","volume":"189","author":"Mendon\u00e7a","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101700_bib14","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/cid\/civ004","article-title":"Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations","volume":"60","author":"Monge-Maillo","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101700_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2014.09.014","article-title":"Cutaneous and mucocutaneous leishmaniasis: differential diagnosis, diagnosis, histopathology, and management","volume":"73","author":"Handler","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tmaid.2020.101700_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.16-84256","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the infectious diseases society of America (IDSA) and the American society of tropical medicine and hygiene (ASTMH)","volume":"96","author":"Aronson","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2020.101700_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1586\/eri.10.19","article-title":"Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis","volume":"8","author":"Goto","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.tmaid.2020.101700_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004495","article-title":"Treatment of cutaneous leishmaniasis caused by leishmania aethiopica: a systematic review","volume":"10","author":"van Griensven","year":"2016","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2020.101700_bib19","unstructured":"WHO. Status of endemicity of cutaneous leishmaniasis worldwide 2015."},{"key":"10.1016\/j.tmaid.2020.101700_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000258675","article-title":"Localized cutaneous leishmaniasis due to leishmania infantum in a patient treated with infliximab","volume":"220","author":"Hakimi","year":"2010","journal-title":"Dermatology (Basel)"},{"key":"10.1016\/j.tmaid.2020.101700_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jfo.2012.06.007","article-title":"[Infectious complications in patients treated with anti-TNF-\u03b1: two cases of leishmaniasis]","volume":"35","author":"Bousquet","year":"2012","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.tmaid.2020.101700_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/00365548.2012.752859","article-title":"Cutaneous leishmaniasis in a patient receiving infliximab","volume":"45","author":"Hern\u00e1ndez-Torres","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101700_bib23","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ad.2013.08.011","article-title":"Cutaneous leishmaniasis in a patient receiving infliximab for psoriatic arthritis: treatment with cryotherapy and intralesional meglumine antimonate","volume":"105","author":"Catal\u00e0","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.tmaid.2020.101700_bib24","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.gastrohep.2015.03.003","article-title":"[Cutaneous leishmaniasis in a patient with ulcerative colitis under treatment with infliximab]","volume":"38","author":"Fern\u00e1ndez","year":"2015","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.tmaid.2020.101700_bib25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/ced.13061","article-title":"Cutaneous leishmaniasis associated with anti-tumour necrosis factor-\u03b1 drugs: an emerging disease","volume":"42","author":"Marcoval","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.tmaid.2020.101700_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4269\/ajtmh.2009.81.52","article-title":"Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab","volume":"81","author":"Mueller","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl 2","key":"10.1016\/j.tmaid.2020.101700_bib27","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S0929-693X(09)75316-3","article-title":"[Pseudotumoral-like recurrence of visceral leishmaniasis in a seven-year-old girl]","volume":"16","author":"Jeziorski","year":"2009","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.tmaid.2020.101700_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/1756-185X.12970","article-title":"Comparison of the risk of infections in different anti-TNF agents: a meta-analysis","volume":"20","author":"Liao","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.tmaid.2020.101700_bib29","article-title":"Safety of tumor necrosis factor-\u03b1 inhibitors for treatment of ankylosing spondylitis: a meta-analysis","volume":"96","author":"Ma","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.tmaid.2020.101700_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/20477724.2016.1232042","article-title":"Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review","volume":"110","author":"Maspi","year":"2016","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.tmaid.2020.101700_bib31","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.4049\/jimmunol.166.6.4012","article-title":"Rapidly fatal leishmaniasis in resistant C57BL\/6 mice lacking TNF","volume":"166","author":"Wilhelm","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.tmaid.2020.101700_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/dth.12083","article-title":"Visceral leishmaniasis with cutaneous symptoms in a patient treated with infliximab followed by fatal consequences","volume":"27","author":"Juzlova","year":"2014","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.tmaid.2020.101700_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdermsci.2018.07.005","article-title":"Combination of paromomycin plus human anti-TNF-\u03b1 antibodies to control the local inflammatory response in BALB\/mice with cutaneous leishmaniasis lesions","author":"Schwartz","year":"2018","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.tmaid.2020.101700_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cimid.2017.02.001","article-title":"Wound healing in cutaneous leishmaniasis: a double edged sword of IL-10 and TGF-\u03b2","volume":"51","author":"Abdoli","year":"2017","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101700_bib35","first-page":"192","article-title":"Anti-tumor necrosis factor-\u03b1 therapy provokes latent leishmaniasis in a patient with rheumatoid arthritis","volume":"39","author":"Franklin","year":"2009","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.tmaid.2020.101700_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-204914","article-title":"Atypical cutaneous leishmaniasis in the immunosuppressed","volume":"2014","author":"Micallef","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.tmaid.2020.101700_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5070\/D30C96W76K","article-title":"Cutaneous leishmaniasis with histopathologic pattern of non-necrotizing granulomatous dermatitis in patients treated with adalimumab","volume":"18","author":"Romero-Mat\u00e9","year":"2012","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.tmaid.2020.101700_bib38","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/rheumatology\/kes030","article-title":"Mucocutaneous leishmaniasis in a patient treated with anti-TNF-\u03b1 therapy","volume":"51","author":"Garcia-Gonzalez","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.tmaid.2020.101700_bib39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000370238","article-title":"Anti-tumour necrosis factor-induced visceral and cutaneous leishmaniasis: case report and review of the literature","volume":"230","author":"Catal\u00e0","year":"2015","journal-title":"Dermatology (Basel)"},{"key":"10.1016\/j.tmaid.2020.101700_bib40","first-page":"447","article-title":"Cutaneous leishmaniasis in a patient with ankylosing spondylitis using adalimumab","volume":"52","author":"Gomes","year":"2012","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.tmaid.2020.101700_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.04.2010.2878","article-title":"Let off the leash: kala-azar following the use of tumour necrosis factor antibodies","volume":"2010","author":"Khan","year":"2010","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.tmaid.2020.101700_bib42","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2340\/00015555-0633","article-title":"Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis","volume":"89","author":"Balt\u00e0-Cruz","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.tmaid.2020.101700_bib43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/ced.13307","article-title":"Cutaneous leishmaniasis mimicking dactylitis in a patient with rheumatoid arthritis treated with certolizumab","volume":"43","author":"Herrerias-Moreno","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.tmaid.2020.101700_bib44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10354-016-0527-1","article-title":"Cutaneous and visceral leishmaniasis during anti-TNF\u03b1 therapy","volume":"167","author":"Guarneri","year":"2017","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.tmaid.2020.101700_bib45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.eimc.2011.06.010","article-title":"[Persistent inflammation of the nasal dorsum in a patient with rheumatoid arthritis treated with infliximab]","volume":"30","author":"Garc\u00eda-Castro","year":"2012","journal-title":"Enferm Infecc Microbiol Cl\u00edn"},{"key":"10.1016\/j.tmaid.2020.101700_bib46","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4269\/ajtmh.2011.10-0712","article-title":"Case report: successful treatment of cutaneous leishmaniasis caused by Leishmania aethiopica with liposomal amphothericin B in an immunocompromised traveler returning from Eritrea","volume":"84","author":"Zanger","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2020.101700_bib47","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3201\/eid1506.090101","article-title":"Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe","volume":"15","author":"Xynos","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101700_bib48","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/ard.2010.137422","article-title":"Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry","volume":"70","author":"Salmon-Ceron","year":"2011","journal-title":"Ann Rheum Dis"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147789392030168X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147789392030168X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:06:46Z","timestamp":1761487606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147789392030168X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":48,"alternative-id":["S147789392030168X"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2020.101700","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relapsing cutaneous leishmaniasis in a patient requiring TNF-\u03b1-inhibitor Infliximab for Takayasu-arteritis: Case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2020.101700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101700"}}